p27 ACTIVATES CDK4 AND BLOCKS PALBOCICLIB-MEDIATED CDK4 INHIBITION

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2020年 / 10卷 / 02期
关键词：
D O I：
10.1158/2159-8290.CD-RW2020-001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [21] Palbociclib-mediated cell cycle arrest can occur in the absence of the CDK inhibitors p21 and p27
    Pennycook, Betheney R.
    Barr, Alexis R.
    OPEN BIOLOGY, 2021, 11 (11)
  • [22] CDK4/6 Inhibition as a therapeutic strategy in breast cancer: palbociclib, ribociclib, and abemaciclib
    Laderian, Bahar
    Fojo, Tito
    SEMINARS IN ONCOLOGY, 2017, 44 (06) : 395 - 403
  • [23] CDK4 as a Prognostic Marker of Hepatocellular Carcinoma and CDK4 Inhibitors as Potential Therapeutics
    Lai, Fobao
    Fang, Yingbing
    Cheng, Cong
    Zhong, Xuejing
    Zheng, Wanrong
    Lan, Shiqian
    Peng, Quanshui
    Cai, Xiumei
    Cao, Tiantian
    Zhong, Chengqian
    Gao, Yuzhen
    CURRENT MEDICINAL CHEMISTRY, 2025, 32 (02) : 343 - 358
  • [24] Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A
    Javier Martin-Broto
    Jeronimo Martinez-Garcia
    David S. Moura
    Andres Redondo
    Antonio Gutierrez
    Antonio Lopez-Pousa
    Javier Martinez-Trufero
    Isabel Sevilla
    Roberto Diaz-Beveridge
    Maria Pilar Solis-Hernandez
    Amancio Carnero
    Marco Perez
    David Marcilla
    Jesus Garcia-Foncillas
    Pablo Romero
    Javier Fernandez-Jara
    Daniel Lopez-Lopez
    Ivan Arribas
    Nadia Hindi
    Signal Transduction and Targeted Therapy, 8
  • [25] CDK4/6 inhibitors
    不详
    CHEMICAL & ENGINEERING NEWS, 2016, : 30 - 31
  • [26] Combined CDK2 and CDK4/6 Inhibition Overcomes Palbociclib Resistance in Breast Cancer by Enhancing Senescence
    Pandey, Kamal
    Park, Nahee
    Park, Kyung-Soon
    Hur, Jin
    Cho, Yong Bin
    Kang, Minsil
    An, Hee-Jung
    Kim, Sewha
    Hwang, Sohyun
    Moon, Yong Wha
    CANCERS, 2020, 12 (12) : 1 - 17
  • [27] p27及CDK4与结肠癌的研究进展
    吕俊
    徐亮
    易礼俊
    夏冬
    西南军医, 2012, 14 (06) : 891 - 894
  • [28] Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A
    Martin-Broto, Javier
    Martinez-Garcia, Jeronimo
    Moura, David S.
    Redondo, Andres
    Gutierrez, Antonio
    Lopez-Pousa, Antonio
    Martinez-Trufero, Javier
    Sevilla, Isabel
    Diaz-Beveridge, Roberto
    Solis-Hernandez, Maria Pilar
    Carnero, Amancio
    Perez, Marco
    Marcilla, David
    Garcia-Foncillas, Jesus
    Romero, Pablo
    Fernandez-Jara, Javier
    Lopez-Lopez, Daniel
    Arribas, Ivan
    Hindi, Nadia
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [29] A role for Cdk4 in angiogenesis
    Baker, Stacey J.
    CELL CYCLE, 2010, 9 (13) : 2493 - 2493
  • [30] CDK4 suppresses gluconeogenesis
    Kirsty Minton
    Nature Reviews Molecular Cell Biology, 2014, 15 (7) : 429 - 429
12345